Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Dec 15, 2023 11:26am
69 Views
Post# 35786741

RE:RE:RE:RE:Game Changing?

RE:RE:RE:RE:Game Changing? "I say again what has always been touted by Gilles and Ronnie as game changing is about to be sold for 20 million not even in cash."

You think you can change the game globally with $11 million cash, a ~40 person operation in Edmonton, and a TSX-V listing. Gilles is a big, global thinker and is eyeing $60 million cash, a diagnostic cashcow, a massive tax shield, and a North American and European footprint ahead of game-changing global PGX deals as well as the NASDAQ big stage with analyst support to get the message out.  
<< Previous
Bullboard Posts
Next >>